{
  "trial_id": "NCT01431391",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, ECOG performance status, PSA level, testosterone level, hematologic function, renal function, liver function, prior primary therapy for prostate cancer, PSADT (Prostate-Specific Antigen Doubling Time), history of allergic reactions, history of other malignancies, prior sipuleucel-T therapy, prior ADT therapy, history of experimental immunotherapy, history of denosumab or XRT, history of chemotherapy or GM-CSF, history of major surgery, history of systemic immunosuppressive therapy, history of other prescription treatment for prostate cancer, presence of active infection, likelihood of receiving XRT or surgery during the study period.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Gleason Score"
      ],
      "remaining_candidate_features": [
        "PSA level",
        "testosterone level",
        "hematologic function",
        "renal function",
        "liver function",
        "prior primary therapy for prostate cancer",
        "PSADT (Prostate-Specific Antigen Doubling Time)",
        "history of allergic reactions",
        "history of other malignancies",
        "prior sipuleucel-T therapy",
        "prior ADT therapy",
        "history of experimental immunotherapy",
        "history of denosumab or XRT",
        "history of chemotherapy or GM-CSF",
        "history of major surgery",
        "history of systemic immunosuppressive therapy",
        "history of other prescription treatment for prostate cancer",
        "presence of active infection",
        "likelihood of receiving XRT or surgery during the study period."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG performance status, PSA levels, Testosterone levels, Hematologic function, Renal function, Liver function, Prior primary therapy for prostate cancer,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Male",
          "Sex: Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Race (NIH/OMB)",
        "Gleason Score"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "PSA levels",
        "Testosterone levels",
        "Hematologic function",
        "Renal function",
        "Liver function",
        "Prior primary therapy for prostate cancer"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, PSA Doubling Time, Testosterone Level, Hematologic Function, Renal Function, Liver Function, Prior Primary Therapy for Prostate Cancer.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Male",
          "Sex: Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Race (NIH/OMB)",
        "Gleason Score"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "PSA Doubling Time",
        "Testosterone Level",
        "Hematologic Function",
        "Renal Function",
        "Liver Function",
        "Prior Primary Therapy for Prostate Cancer."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, race, ethnicity, ECOG performance status, PSA value, PSADT, testosterone level, hematologic parameters (e.g., WBC, hemoglobin, platelet count), renal function (e.g., creatinine, eGFR), liver function (e.g., ALT, AST, bilirubin), medical history (e.g., prior primary therapy for prostate cancer, history of malignancy), body mass index (BMI), smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Gleason Score"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "PSA value",
        "PSADT",
        "testosterone level",
        "hematologic parameters (e.g., WBC, hemoglobin, platelet count)",
        "renal function (e.g., creatinine, eGFR)",
        "liver function (e.g., ALT, AST, bilirubin)",
        "medical history (e.g., prior primary therapy for prostate cancer, history of malignancy)",
        "body mass index (BMI)",
        "smoking status"
      ]
    }
  }
}